Use of the Heartmate 3 for biventricular support as a bridge to heart transplant-first US implant

Aditya Bansal; Faisal Akhtar; Nathan P Zwintscher; Sheila Ostrow; Sapna Desai; David Fary

doi:10.1111/jocs.14290

Use of the Heartmate 3 for biventricular support as a bridge to heart transplant-first US implant

J Card Surg. 2019 Dec;34(12):1629-1631. doi: 10.1111/jocs.14290. Epub 2019 Oct 14.

Authors

Aditya Bansal¹, Faisal Akhtar¹, Nathan P Zwintscher¹, Sheila Ostrow¹, Sapna Desai², David Fary¹

Affiliations

¹ Section of Cardiothoracic Surgery, Ochsner Clinic Foundation, New Orleans, Louisiana.
² Section of Heart Failure, Ochsner Clinic Foundation, New Orleans, Louisiana.

PMID: 31609485
DOI: 10.1111/jocs.14290

Abstract

Right ventricular failure continues to be the Achilles heel in the management of heart failure patients. Traditionally, either high doses of inotropes and inhaled nitric oxide or jerry-rigged temporary mechanical devices have been used to support failing right ventricles. No durable implantable right ventricular assist device has been developed to address this long-standing concern. Because of this vacuum of innovation, surgeons have started using the third-generation LVADs to support the right ventricle. The HeartMate 3 (Abbott) LVAD is a safe and effective therapy for the management of biventricular failure.

Keywords: MCS; adult; cardiac; transplant.

Publication types

Case Reports

MeSH terms

Equipment Design
Heart Failure / therapy*
Heart Transplantation
Heart-Assist Devices*
Humans
Male
Middle Aged